Drug Interaction Report

Nateglinide and Sulfinpyrazone: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sulfinpyrazone

No brand names on record
+

Nateglinide

Starlix®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Minor
Usually limited clinical impact.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 209 documented Nateglinide interactions, 1 is rated minor — including this one.
Onset
delayed
Evidence
probable
Severity
Minor

What happens

Increased nateglinide bioavailability

Interaction Deep Dive

The coadministration of sulfinpyrazone with nateglinide produced statistically significant, yet modest increases in nateglinide bioavailability. The effect of sulfinpyrazone upon steady-state nateglinide dosing was not addressed during the study1.

Why it happens (mechanism)

Inhibition of P450-2C9-mediated nateglinide metabolism

Literature reports

1 report — tap to read

a) The coadministration of sulfinpyrazone with nateglinide produced statistically significant, yet modest increases in nateglinide bioavailability. In an open-label, randomized, 2-phase crossover pharmacokinetic study, healthy subjects (n=16) received a single oral dose of nateglinide 120 milligrams (mg) alone on study day 1, or after an overnight fast on the final day of a 7-day regimen of sulfinpyrazone 200 mg twice daily. Nateglinide plasma concentrations were measured by serial blood analysis performed over the 24-hour post-dose time period. The maximum serum concentration of nateglinide (Cmax) and time to maximum concentration (Tmax) were unaffected by concomitant administration of sulfinpyrazone; however, a modest yet statistically significant increase (28%) was observed in nateglinide area under the concentration-time curve (AUC - 0 to infinity). The geometric mean ratio for the AUC (0-infinity) was 1.28 (90% confidence interval, 1.19 to 1.37; p less than 0.01). While there were no occurrences of hypoglycemia observed throughout the study, the effect of sulfinpyrazone upon steady-state nateglinide dosing was not addressed 1.

Common questions

Can I take Nateglinide and Sulfinpyrazone together?

Increased nateglinide bioavailability Always confirm with your pharmacist or prescriber before making any change.

How serious is the Nateglinide and Sulfinpyrazone interaction?

It is rated minor. Usually limited clinical impact.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Nateglinide or Sulfinpyrazone need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (1)

  1. Sabia H, Sunkara G, Ligueros-Saylan M, et al: Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects. Eur J Clin Pharmacol 2004; 60:407-412. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.